United States of America

Choose your country or region

Select your country or region

Lumipulse^® G SARS-CoV-2 N-IgG

Lumipulse G SARS-CoV-2 N-IgG is an assay system, including a set of immunoassay reagents, for the quantitative measurement of IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma. SARS-CoV-2 N antibody measurement is intended to be used as an aid in the assessment of immune response to the SARS-CoV-2 N protein.

CE marked

Lumipulse® G SARS-CoV-2 N-IgG IRC

Product number 232323

3 x 14 Tests

Contact sales for information and inquiries

Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

Details
Conditions of sale
Documentation
Insights
Related products
Product inquiry

Details

See the LUMIPULSE G1200 working in this video:
Conditions of sale

To read the end user conditions of sale for this product please visit our Resource center.
Documentation

Browse regulatory documents for this product

Create a (free!) eServices account and start browsing all regulatory documentation right away.

Register now or Sign in
Get access to this section and more

Create a free eServices account now and instantly access multiple digital resources:

Regulatory product documentation

Selected scientific posters

Product leaflets

How-to videos and more…

Register now or Sign in
Insights

Lung disease

This scientific literature overview demonstrates the excellent performance of the fully automated nucleocapsid protein antigen assay Lumipulse® G SARS-CoV-2 Ag

Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.

...

May 27, 2021

Read more

Lung disease

Large-scale and fully automated COVID-19 antigen testing for travelers in German airports

Since November 2020 Fujirebio Europe and CENTOGENE have partnered to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing in...

May 11, 2021

Read more

Lung disease

Webinar: Lumipulse® G KL-6, the biomarker for routinely assessment of epithelial alveolar damage in pulmonary fibrosis and COVID-19

During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...

Oct 19, 2020

Read more
Related products

Lumipulse^® G SARS-CoV-2 N-IgG Controls

Product number 232354 -

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System.

CE marked

Detail

Lumipulse^® G SARS-CoV-2 S-IgG

Product number 232231 -

For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System.

CE marked

Detail

Lumipulse^® G SARS-CoV-2 Ag

Product number 260340, 231869 -

For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.

CE marked

Detail

Lumipulse^® G KL-6 (Krebs von den Lungen)

Product number 233207 -

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.

CE marked

Detail

LUMIPULSE^® G600II

Product number 703380 -

The LUMIPULSE G600II is the latest member of the Lumipulse G series of chemiluminescent enzyme immunoassay analyzers (CLEIA) from Fujirebio.

CE marked

Detail

LUMIPULSE^® G1200

Product number 232002 -

A robust, mid-sized and fully automated chemiluminescent enzyme immunoassay (CLEIA) system from the already widely successful LUMIPULSE series.

CE marked

Detail

iAMP COVID-19 Detection Kit

Product number 80767, 80762 -

Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.

CE marked

Detail

iAMP COVID-19 SANO Assay

Product number 81104, 80762, 80812 -

Qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.

CE marked

Detail
Product inquiry

Salutation

First name

Last name

E-mail

Phone number

Organization / company

Company type

Function / job title

Message or question

Request support for

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

Leave this field blank

Your local distributor(s) for this product

Fujirebio US, Inc.

205 Great Valley Parkway
Malvern, PA 19355
United States

001 877.861.7246
Toll-free: +1 877.861.7246. Hours of operation: Monday to Friday from 8:30am – 5:30pm EST.

Product support
001 877.861.7246

site by D'M&S

Close